Plasmablasts With a Mucosal Phenotype Contribute to Plasmacytosis in Systemic Lupus Erythematosus

Arthritis and Rheumatology

Volumn 69, Issue 10, 2017, Pages 2018-2028

  Mei, Henrik E ^a   Hahne, Stefanie ^a   Redlin, Andreas ^a   Hoyer, Bimba F ^a   Wu, Kaiyin ^a   Baganz, Lisa ^b   Lisney, Anna R ^a   Alexander, Tobias ^a   Rudolph, Birgit ^a   Dörner, Thomas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b German Rheumatism Research Center Berlin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA7 INTEGRIN; CCL28 CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR CCR10; CHOLERA VACCINE; DIPHTHERIA TETANUS VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 2; PLATELET DERIVED GROWTH FACTOR BB; UNCLASSIFIED DRUG; AUTOANTIBODY; BECAPLERMIN; BETA CHEMOKINE; BETA INTEGRIN; CCL28 PROTEIN, HUMAN; CCR10 PROTEIN, HUMAN; CYTOKINE; IL2 PROTEIN, HUMAN; PLATELET DERIVED GROWTH FACTOR B;

ANTIBODY SECRETING CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL HOMING; CELL MIGRATION ASSAY; CHOLERA; CONTROLLED STUDY; DIPHTHERIA; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN PRODUCTION; IMMUNOREACTIVITY; KIDNEY BIOPSY; LYMPHOCYTE MIGRATION; MAJOR CLINICAL STUDY; MUCOSA; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PLASMABLAST; PLASMACYTOSIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TETANUS; TISSUE SECTION; VACCINATION; ADOLESCENT; ADULT; AGED; CASE CONTROL STUDY; CELL DIFFERENTIATION; CELL MOTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOLOGY; IN VITRO STUDY; KIDNEY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MIDDLE AGED; PATHOLOGY; PLASMA CELL; PRE B LYMPHOCYTE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL MOVEMENT; CHEMOKINES, CC; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IN VITRO TECHNIQUES; INTEGRIN BETA CHAINS; INTERLEUKIN-2; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PHENOTYPE; PLASMA CELLS; PRECURSOR CELLS, B-LYMPHOID; PROTO-ONCOGENE PROTEINS C-SIS; RECEPTORS, CCR10; YOUNG ADULT;

EID: 85030984024     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.40181     Document Type: Article

References (55)

1. Wahren-Herlenius M, Dörner T. Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 2013;382:819–31.
2. Odendahl M, Jacobi A, Hansen A, Feist E, Hiepe F, Burmester GR, et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 2000;165:5970–9.
3. Kaminski DA, Wei C, Qian Y, Rosenberg AF, Sanz I. Advances in human B cell phenotypic profiling. Front Immunol 2012;3:302.
4. high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 2003;48:1332–42.
5. Hiepe F, Dörner T, Hauser AE, Hoyer BF, Mei H, Radbruch A. Long-lived autoreactive plasma cells drive persistent autoimmune inflammation. Nat Rev Rheumatol 2011;7:170–8.
6. Mei HE, Yoshida T, Sime W, Hiepe F, Thiele K, Manz RA, et al. Blood-borne human plasma cells in steady state are derived from mucosal immune responses. Blood 2009;113:2461–9.
7. Mora JR, von Andrian UH. Differentiation and homing of IgA-secreting cells. Mucosal Immunol 2008;1:96–109.
8. Kutteh WH, Prince SJ, Mestecky J. Tissue origins of human polymeric and monomeric IgA. J Immunol 1982;128:990–5.
9. Berlin C, Berg EL, Briskin MJ, Andrew DP, Kilshaw PJ, Holzmann B, et al. α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993;74:185–95.
10. Briskin M, Winsor-Hines D, Shyjan A, Cochran N, Bloom S, Wilson J, et al. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol 1997;151:97–110.
11. Mora JR, Iwata M, Eksteen B, Song SY, Junt T, Senman B, et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 2006;314:1157–60.
12. Ruane D, Chorny A, Lee H, Faith J, Pandey G, Shan M, et al. Microbiota regulate the ability of lung dendritic cells to induce IgA class-switch recombination and generate protective gastrointestinal immune responses. J Exp Med 2016;213:53–73.
13. Wang W, Soto H, Oldham ER, Buchanan ME, Homey B, Catron D, et al. Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). J Biol Chem 2000;275:22313–23.
14. Homey B, Wang W, Soto H, Buchanan ME, Wiesenborn A, Catron D, et al. The orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol 2000;164:3465–70.
15. Kunkel EJ, Kim CH, Lazarus NH, Vierra MA, Soler D, Bowman EP, et al. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J Clin Invest 2003;111:1001–10.
16. Pabst R, Russell MW, Brandtzaeg P. Tissue distribution of lymphocytes and plasma cells and the role of the gut. Trends Immunol 2008;29:206–8.
17. Brandtzaeg P, Johansen FE. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev 2005;206:32–63.
18. Jaimes MC, Rojas OL, Kunkel EJ, Lazarus NH, Soler D, Butcher EC, et al. Maturation and trafficking markers on rotavirus-specific B cells during acute infection and convalescence in children. J Virol 2004;78:10967–76.
19. Sundstrom P, Lundin SB, Nilsson LA, Quiding-Jarbrink M. Human IgA-secreting cells induced by intestinal, but not systemic, immunization respond to CCL25 (TECK) and CCL28 (MEC). Eur J Immunol 2008;38:3327–38.
20. Kunkel EJ, Butcher EC. Plasma-cell homing. Nat Rev Immunol 2003;3:822–9.
21. Seong Y, Lazarus NH, Sutherland L, Habtezion A, Abramson T, He XS, et al. Trafficking receptor signatures define blood plasmablasts responding to tissue-specific immune challenge. JCI Insight 2017;2:e90233.
22. Hanaoka H, Okazaki Y, Satoh T, Kaneko Y, Yasuoka H, Seta N, et al. Circulating anti-double-stranded DNA antibody-secreting cells in patients with systemic lupus erythematosus: a novel biomarker for disease activity. Lupus 2012;21:1284–93.
23. Odendahl M, Mei H, Hoyer BF, Jacobi AM, Hansen A, Muehlinghaus G, et al. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 2005;105:1614–21.
24. + plasmablasts is not abrogated by B-cell depletion therapy with rituximab. Blood 2010;116:5181–90.
25. Mei HE, Wirries I, Frolich D, Brisslert M, Giesecke C, Grun JR, et al. A unique population of IgG-expressing plasma cells lacking CD19 is enriched in human bone marrow. Blood 2015;125:1739–48.
26. Carpenter J, Bithell J. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med 2000;19:1141–64.
27. Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008;453:667–71.
28. Erickson LD, Lin LL, Duan B, Morel L, Noelle RJ. A genetic lesion that arrests plasma cell homing to the bone marrow. Proc Natl Acad Sci U S A 2003;100:12905–10.
29. Yoshida T, Mei H, Dörner T, Hiepe F, Radbruch A, Fillatreau S, et al. Memory B and memory plasma cells. Immunol Rev 2010;237:117–39.
30. Ginsburg WW, Finkelman FD, Lipsky PE. Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus. Clin Exp Immunol 1979;35:76–88.
31. Joo H, Coquery C, Xue Y, Gayet I, Dillon SR, Punaro M, et al. Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation. J Exp Med 2012;209:1335–48.
32. Wangel AG, Milton A, Egan JB. Spontaneous plaque forming cells in the peripheral blood of patients with systemic lupus erythematosus. Clin Exp Immunol 1982;49:41–9.
33. Saiki O, Saeki Y, Kishimoto S. Spontaneous immunoglobulin A secretion and lack of mitogen-responsive B cells in systemic lupus erythematosus. J Clin Invest 1985;76:1865–70.
34. Blanchard-Rohner G, Pulickal AS, Jol-van der Zijde CM, Snape MD, Pollard AJ. Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humans. Blood 2009;114:4998–5002.
35. Quiding-Jarbrink M, Nordstrom I, Granstrom G, Kilander A, Jertborn M, Butcher EC, et al. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations: a molecular basis for the compartmentalization of effector B cell responses. J Clin Invest 1997;99:1281–6.
36. Heine G, Drozdenko G, Lahl A, Unterwalder N, Mei H, Volk HD, et al. Efficient tetanus toxoid immunization on vitamin D supplementation. Eur J Clin Nutr 2011;65:329–34.
37. Lemke A, Kraft M, Roth K, Riedel R, Lammerding D, Hauser AE. Long-lived plasma cells are generated in mucosal immune responses and contribute to the bone marrow plasma cell pool in mice. Mucosal Immunol 2016;9:83–97.
38. high plasmablasts indicate active disease in patients with systemic lupus erythematosus. Ann Rheum Dis 2010;69:305–8.
39. Floege J, Eitner F, Alpers CE. A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 2008;19:12–23.
40. Rosengren S, Corr M, Boyle DL. Platelet-derived growth factor and transforming growth factor β synergistically potentiate inflammatory mediator synthesis by fibroblast-like synoviocytes. Arthritis Res Ther 2010;12:R65.
41. Tang J, Kozaki K, Farr AG, Martin PJ, Lindahl P, Betsholtz C, et al. The absence of platelet-derived growth factor-B in circulating cells promotes immune and inflammatory responses in atherosclerosis-prone ApoE−/− mice. Am J Pathol 2005;167:901–12.
42. Stavnezer J, Kang J. The surprising discovery that TGFβ specifically induces the IgA class switch. J Immunol 2009;182:5–7.
43. Von Spee-Mayer C, Siegert E, Abdirama D, Rose A, Klaus A, Alexander T, et al. Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus. Ann Rheum Dis 2016;75:1407–15.
44. + T cell subsets in patients with systemic lupus erythematosus. Nat Med 2016;22:991–3.
45. Cong Y, Feng T, Fujihashi K, Schoeb TR, Elson CO. A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota. Proc Natl Acad Sci U S A 2009;106:19256–61.
46. Adrych K, Smoczynski M, Stojek M, Sledzinski T, Korczynska J, Goyke E, et al. Coordinated increase in serum platelet-derived growth factor-BB and transforming growth factor-β1 in patients with chronic pancreatitis. Pancreatology 2011;11:434–40.
47. + B cell population belongs to the memory B cell pool. Scand J Immunol 2007;66:77–86.
48. Cassese G, Arce S, Hauser AE, Lehnert K, Moewes B, Mostarac M, et al. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J Immunol 2003;171:1684–90.
49. Jego G, Bataille R, Pellat-Deceunynck C. Interleukin-6 is a growth factor for nonmalignant human plasmablasts. Blood 2001;97:1817–22.
50. Gonzalez-Garcia I, Ocana E, Jimenez-Gomez G, Campos-Caro A, Brieva JA. Immunization-induced perturbation of human blood plasma cell pool: progressive maturation, IL-6 responsiveness, and high PRDI-BF1/BLIMP1 expression are critical distinctions between antigen-specific and nonspecific plasma cells. J Immunol 2006;176:4042–50.
51. Ramsay AJ, Husband AJ, Ramshaw IA, Bao S, Matthaei KI, Koehler G, et al. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 1994;264:561–3.
52. Hatton RD. TGF-β in Th17 cell development: the truth is out there. Immunity 2011;34:288–90.
53. Hirota K, Turner JE, Villa M, Duarte JH, Demengeot J, Steinmetz OM, et al. Plasticity of Th17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses. Nat Immunol 2013;14:372–9.
54. Martin JC, Baeten DL, Josien R. Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus. Clin Immunol 2014;154:1–12.
55. Todd DJ, Knowlton N, Amato M, Frank MB, Schur PH, Izmailova ES, et al. Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor. Arthritis Rheum 2011;63:894–903.